600211 西藏藥業
按盤價 
32.730 -0.280 (-0.848%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 8.936 | 25.200 | 13.110 | 8.026 | 16.680 |
| 總資產報酬率 ROA (%) | 6.467 | 18.439 | 9.360 | 6.194 | 14.640 |
| 投入資產回報率 ROIC (%) | 7.544 | 21.711 | 11.028 | 7.230 | 16.625 | 邊際利潤分析 |
| 銷售毛利率 (%) | 94.832 | 95.052 | 94.258 | 89.562 | 85.801 |
| 營業利潤率 (%) | 49.312 | 28.685 | 18.189 | 12.008 | 34.383 |
| 息稅前利潤/營業總收入 (%) | 45.996 | 27.581 | 18.307 | 12.232 | 33.266 |
| 淨利潤/營業總收入 (%) | 44.765 | 25.851 | 14.691 | 9.961 | 30.636 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 74.857 | 119.799 | 160.019 | 222.558 | 89.722 |
| 價值變動淨收益/利潤總額(%) | 0.096 | -18.937 | -1.541 | 57.474 | 0.202 |
| 營業外收支淨額/利潤總額(%) | 0.050 | -0.100 | -0.272 | -0.765 | -0.383 | 償債能力分析 |
| 流動比率 (X) | 2.865 | 2.873 | 2.643 | 1.966 | 4.056 |
| 速動比率 (X) | 2.785 | 2.779 | 2.545 | 1.843 | 3.844 |
| 資產負債率 (%) | 27.456 | 26.458 | 26.072 | 30.443 | 0.121 |
| 帶息債務/全部投入資本 (%) | 16.855 | 12.565 | 13.210 | 15.985 | 0.128 |
| 股東權益/帶息債務 (%) | 489.231 | 689.815 | 647.811 | 516.180 | 77,614.078 |
| 股東權益/負債合計 (%) | 261.875 | 275.561 | 281.766 | 227.218 | 723.810 |
| 利息保障倍數 (X) | -13.766 | -25.643 | 108.986 | 38.756 | -33.728 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 69.741 | 63.038 | 64.691 | 67.692 | 83.922 |
| 存貨周轉天數 (天) | 273.014 | 245.342 | 291.134 | 167.867 | 134.294 |
| 備註： | 即時報價更新時間為 03/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
